Emerging role of Dupilumab for COPD with type 2 inflammation
Main Article Content
Downloads
Download data is not yet available.
Article Details
Issue
Section
Breath-Taking News

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright and grant the journal right of first publication.
How to Cite
1.
Manga J. Emerging role of Dupilumab for COPD with type 2 inflammation. Afr J Thoracic Crit Care Med [Internet]. 2026 Jul. 3 [cited 2026 Jul. 5];32(2). Available from: https://samajournals.co.za/index.php/ajtccm/article/view/5486
References
1. Bhatt SP, Rabe KF, Hanania NA, et al. Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts. N Engl J Med 2023;389(3):205-214. https://doi.org/10.1056/NEJMoa2303951.
2. Bhatt SP, Rabe KF, Hanania NA, et al. Dupilumab for COPD with blood eosinophil evidence of type 2 inflammation. N Engl J Med 2024;390(24):2274-2283. https://doi.org/10.1056/NEJMoa2401304